Home

Insights

PE

Kwality Pharmaceuticals Ltd P/E Ratio

Kwality Pharmaceuticals Ltd P/E Ratio

download
stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

3.9 K

stocks traded

Last Updated time: 12 Jul 15:30 PM

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

PE

17.8

Last updated : 12 Jul 15:30 PM

Key Highlights

    The P/E Ratio of Kwality Pharmaceuticals Ltd is 17.8 as of 12 Jul 15:30 PM .a1#The P/E Ratio of Kwality Pharmaceuticals Ltd changed from 5.1 on March 2019 to 16.5 on March 2023 . This represents a CAGR of 26.47% over 5 years. a1#The Latest Trading Price of Kwality Pharmaceuticals Ltd is ₹ 497.05 as of 12 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.7. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Pharmaceuticals industry is 37.3. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of Kwality Pharmaceuticals Ltd changed from ₹ 38.44 crore on March 2019 to ₹ 319.12 crore on March 2023 . This represents a CAGR of 52.70% over 5 years. a1#The Revenue of Kwality Pharmaceuticals Ltd changed from ₹ 70.6 crore to ₹ 92.56 crore over 8 quarters. This represents a CAGR of 14.50% a1#The EBITDA of Kwality Pharmaceuticals Ltd changed from ₹ 18.38 crore to ₹ 14.11 crore over 8 quarters. This represents a CAGR of -12.38% a1#The Net Pr of Kwality Pharmaceuticals Ltd changed from ₹ 10.52 crore to ₹ 4.24 crore over 8 quarters. This represents a CAGR of -36.51% a1#The Dividend Payout of Kwality Pharmaceuticals Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Kwality Pharmaceuticals Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Kwality Pharmaceuticals Ltd

Period
Mar '195.1
Mar '203.2
Mar '213.8
Mar '225
Mar '2316.5

Company Fundamentals for Kwality Pharmaceuticals Ltd

Market Cap

515 Cr

EPS

28.0

P/E Ratio (TTM) *

17.8

P/B Ratio (TTM) *

2.3

Day’s High

500.9

Day’s Low

491.1

DTE *

0.4

ROE *

13.0

52 Week High

590.0

52 Week Low

308.7

ROCE *

15.1

* All values are consolidated

Last Updated time: 12 Jul 15:30 PM

* All values are consolidated

Last Updated time: 12 Jul 15:30 PM

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

PRICE

497.05

-2.30 (-0.46%)

stock direction

Last updated : 12 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Kwality Pharmaceuticals Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

Asset Value vs Market Value of Kwality Pharmaceuticals Ltd

Market Value

518

Asset Value

214

1.4 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Kwality Pharmaceuticals Ltd17518
Sun Pharmaceuticals Industries Ltd38379,875
Divis Laboratories Ltd76121,620
Cipla Ltd28121,596
Zydus Lifesciences Ltd30117,156
Dr Reddys Laboratories Ltd20110,038

Key Valuation Metric of Kwality Pharmaceuticals Ltd

Earnings

23 Cr

17.8 X

PE Ratio

Market Cap

₹518.14Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

23 Cr

17.8 X

PE Ratio

Market Cap

₹518.14Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Kwality Pharmaceuticals Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Kwality Pharmaceuticals Ltd

Period
Mar '1938
Mar '2027
Mar '2158
Mar '22602
Mar '23319

* All values are a in crore

×

Historical Revenue of Kwality Pharmaceuticals Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Kwality Pharmaceuticals Ltd

Period
Jun '2271
Sep '2257
Dec '2257
Mar '2370
Jun '2368
Sep '2370
Dec '2379
Mar '2493

* All values are a in crore

×

Historical EBITDA of Kwality Pharmaceuticals Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Kwality Pharmaceuticals Ltd

Period
Jun '2218
Sep '2217
Dec '2215
Mar '23-4
Jun '2314
Sep '2315
Dec '2317
Mar '2414

* All values are a in crore

×

Historical Net Profit of Kwality Pharmaceuticals Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Kwality Pharmaceuticals Ltd

Period
Jun '2211
Sep '229
Dec '227
Mar '23-7
Jun '235
Sep '236
Dec '238
Mar '244

* All values are a in crore

×

Historical Dividend Payout of Kwality Pharmaceuticals Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Kwality Pharmaceuticals Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Kwality Pharmaceuticals Ltd

About Kwality Pharmaceuticals Ltd

    Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics. With little background of finished pharmaceuticals and high held spirits and will, he started this business. He received his first drug license in 1981 approved for liquid oral manufacturing. Presently, the Company has 48 different sections available at their production centres. Kwality Pharmaceuticals Ltd. are manufacturer of finished pharmaceutical formulations in a Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectables. The Company has the most modern & sophisticated Plant, Equipment, technique, and workforce. Certified as ISO: 9001:2015 and ISO 14001:2015, it is working with new SCHEDULE M and WHO norms and certified with GMP. The Company is keeping all records of inputs used in manufacturing. The inputs are tested as per standard laid down by company SOP. The in-process testing records are also maintained as per SOP. Similarly, finished goods are also tested as per SOP and are then allowed for sale. Apart from these, the Company is making medicines in various dosage forms like Liquid Orals, Powder for Oral Suspension, Tablets, Capsules, Dry Syrup, Syrup, Sterile Powder for Injections, small volume injectables, Ointments, External Preparations, ORS and many more in various categories like Beta Lactam & non-Beta Lactam, Hormones, Cytotoxic (Oncology) and Effervescent as per new GMP norms. Besides, it manufacture the latest drugs for the management of viral infections/diseases in different dosage forms. Each category of product is processed in a separate section, which is equipped with the latest machinery. All sections are supported by a centralized quality control department which has different segments. Each segment is equipped with the latest scientific machinery, ingredients, and trained staff supported by SOP. These segments are instrumental testing, chemical testing, pyrogen testing, and Bacterial endotoxin testing and microbiology, etc. The Company had put up a multi-storied factory building in Nag Kalan, Amritsar, which started its production in March 2006. The new factory was as per WHO GMP norms. It put up the Jassur Plant in Himachal Pradesh. This unit was in the TAX-free zone, which has helped the Company to sell its Products into the Indian retail market. Kwality Pharmaceuticals, as an exporting company has supplied Remdesivir Injection to the global market and similarly Propofol injection was short in supply in various high profile countries who normally accept US FDA companies' products. But in shortage of medicine, they procured these injections from the Company and after seeing the performance and efficacy, they registered the product. They started procuring the other items of the Company and it became world recognized and now the booking grew which has yielded more sales and profit for the Company.

Kwality Pharmaceuticals Ltd News Hub

News

Kwality Pharmaceuticals to table results

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23...

Read more

09 May 202410:49

News

Kwality Pharmaceuticals to declare Quarterly Result

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 ...

Read more

27 Jan 202416:03

News

Kwality Pharmaceuticals to hold board meeting

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 4 ...

Read more

18 Oct 202310:40

News

Kwality Pharmaceuticals Ltd leads losers in 'B' group

Creative Eye Ltd, Parshva Enterprises Ltd, Baid Finserv Ltd and Steel Exchange India Ltd a...

Read more

06 Oct 202314:45

News

Kwality Pharmaceuticals to conduct AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wil...

Read more

09 Sep 202310:35

News

Kwality Pharmaceuticals schedules board meeting

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10...

Read more

03 Aug 202314:48

Product Composition by Percentage (Revenue)

FAQs for PE of Kwality Pharmaceuticals Ltd

What is Kwality Pharmaceuticals Ltd current share price?

The current market price of Kwality Pharmaceuticals Ltd as of July 12, 2024 is ₹497.05.

What is Kwality Pharmaceuticals Ltd's market cap?

Kwality Pharmaceuticals Ltd's market capitalisation stood at ₹518 Cr as of July 12, 2024

What are Kwality Pharmaceuticals Ltd's total net assets?

According to Kwality Pharmaceuticals Ltd's most recent financial filings, the company's net assets total ₹214.3 Cr.

Is Kwality Pharmaceuticals Ltd making a profit or loss?

Kwality Pharmaceuticals Ltd's net Profit as of July 12, 2024 is close to ₹23 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199